Clinical trialNCT02395367CompletedObservational

Prospective, Observational, Real-world Oral Malignant Tumors Study

SponsorBeijing Stomatological Hospital, Capital Medical UniversityEnrollment30,000Head and Neck NeoplasmsPostoperative ComplicationsQuality of Life

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The aim of the study is to construct a register system of oral and maxillofacial malignant tumors based on a prospective, observational, real-world study in north Chinese population.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Dian-can Wang, M.D.
Department of Oral and Maxillofacial Surgery, School of Stomatology Peking University.
Principal Investigator
clinicaltrials.gov ↗
Qiang Sun, Ph.D.
The First Affiliated Hospital of Zhengzhou University
Principal Investigator
clinicaltrials.gov ↗
Tiancheng Li, M.D.
Department of Otolaryngology, Beijing Chaoyang Hospital, Capital Medical University
Principal Investigator
clinicaltrials.gov ↗
Wei Cao, Ph.D.
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Principal Investigator
clinicaltrials.gov ↗
Xiaolei Liu, Ph.D.
Department of Radiation Oncology, Beijing Shijitan Hospital, Capital Medical University
Principal Investigator
clinicaltrials.gov ↗
Xu Wang, Ph.D.
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Principal Investigator
clinicaltrials.gov ↗
Zhen Wang, Ph.D.
Beijing Friendship Hospital, Capital Medical Universiy
Principal Investigator
clinicaltrials.gov ↗
Zhien Feng, M.D., Ph.D.
Department of Oral and Maxillofacial-Head and Neck Oncology, Beijing Stomatological Hospital, Capital Medical University.
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China

Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Beijing Stomatological Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Department of Otolaryngology, Beijing Chaoyang Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Department of Radiation Oncology, Beijing Shijitan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
School of Stomatology, Peking University
Beijing, Beijing Municipality, China
Department of Oral and Maxillofacial Surgery, First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Department of Oral and Maxillofacial-Head & Neck Oncology, Ninth People'S Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Neoadjuvant chemotherapy or adjuvant chemotherapy

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Mar 2015
Primary completion: 31 Mar 2025
Completion: 31 Mar 2025
Last update posted: 7 Mar 2025
Registered enrollment: 30,000
Registry id: NCT02395367

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.